Nouwen, A.,
Deschenes, S.S.,
Balkhiyarova, Z.,
Albertorio-Diaz, J.R.,
Prokopenko, I.,
Schmitz, N. (2021) -affective items) models were examined. Results: Results demonstrated that the most stringent models,
testing equal
and adaptation to hypoxia. It was assumed that the cuff occlusion
test (COT) would assess the available reserves
Solovyev, A.V.,
Dzhemileva, L.U.,
Posukh, O.L.,
Barashkov, N.A.,
Bady-Khoo, M.S.,
Lobov, S.L.,
Popova, N.Y.,
Romanov, G.P.,
Sazonov, N.N.,
Bondar, A.A.,
Morozov, I.V.,
Tomsky, M.I.,
Fedorova, S.A.,
Khusnutdinova, E.K. (2017) sensory disorder. The
results of the molecular-based studies of HI are widely used
in various genetic
testZhao, X.,
Sun, J.,
Su, W.,
Shan, H.,
Zhang, B.,
Wang, Y.,
Shabanova, A.,
Shan, H.,
Liang, H. (2018) cytoplasm to nucleus, a key downstream effector of the Hippo pathway, in vivo and in
vitro by interacting
to promote heart healing after myocardial infarction (MI). Furthermore, in
vitro and in vivo studies
Chu, Q.,
Jiang, Y.,
Zhang, W.,
Xu, C.,
Du, W.,
Tuguzbaeva, G.,
Qin, Y.,
Li, A.,
Zhang, L.,
Sun, G.,
Cai, Y.,
Feng, Q.,
Li, G.,
Li, Y.,
Yang, B. (2016) both in
vitro and in vivo, which was attenuated by caspase-1 inhibitor Ac-YVAD-CMK. Conclusively
is performed according to the “guidance on preclinical
research of new pharmacological substances” in
vitroDzhemilev, Usein M.,
D’yakonov, Vladimir A.,
Tuktarova, Regina A.,
Dzhemileva, Lilya U.,
Ishmukhametova, Svetlana R.,
Yunusbaeva, Milyausha M.,
Armin de Meijere (2016) . It has been demonstrated for the first time that muricadienin exhibits a moderate in
vitro inhibitory